نيرماترلفير (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "نيرماترلفير" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place
1st place
1st place
11th place
86th place
low place
low place
14th place
41st place
818th place
1,912th place
low place
7,116th place
447th place
393rd place

archive.today

clinicaltrialsarena.com

doi.org

  • Vandyck K، Deval J (أغسطس 2021). "Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection". Current Opinion in Virology. ج. 49: 36–40. DOI:10.1016/j.coviro.2021.04.006. PMC:8075814. PMID:34029993.
  • Schooley RT، Carlin AF، Beadle JR، Valiaeva N، Zhang XQ، Clark AE، وآخرون (سبتمبر 2021). "Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs". Antimicrobial Agents and Chemotherapy. ج. 65 ع. 10: e0115521. DOI:10.1128/AAC.01155-21. PMID:34310217. S2CID:236450769.
  • Yavuz S، Komsuoğlu Çelikyurt FI (أغسطس 2021). "Antiviral treatment of COVID-19: An update". Turkish Journal of Medical Sciences. DOI:10.3906/sag-2106-250. PMID:34391321. S2CID:237054672.
  • Ahmad B، Batool M، Ain QU، Kim MS، Choi S (أغسطس 2021). "Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations". International Journal of Molecular Sciences. ج. 22 ع. 17: 9124. DOI:10.3390/ijms22179124. PMC:8430524. PMID:34502033.
  • Pedersen NC، Kim Y، Liu H، Galasiti Kankanamalage AC، Eckstrand C، Groutas WC، وآخرون (أبريل 2018). "Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis". Journal of Feline Medicine and Surgery. ج. 20 ع. 4: 378–392. DOI:10.1177/1098612X17729626. PMC:5871025. PMID:28901812.
  • Vuong W، Khan MB، Fischer C، Arutyunova E، Lamer T، Shields J، وآخرون (أغسطس 2020). "Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication". Nature Communications. ج. 11 ع. 1: 4282. DOI:10.1038/s41467-020-18096-2. PMC:7453019. PMID:32855413.

fda.gov

nationalpost.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Vandyck K، Deval J (أغسطس 2021). "Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection". Current Opinion in Virology. ج. 49: 36–40. DOI:10.1016/j.coviro.2021.04.006. PMC:8075814. PMID:34029993.
  • Schooley RT، Carlin AF، Beadle JR، Valiaeva N، Zhang XQ، Clark AE، وآخرون (سبتمبر 2021). "Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs". Antimicrobial Agents and Chemotherapy. ج. 65 ع. 10: e0115521. DOI:10.1128/AAC.01155-21. PMID:34310217. S2CID:236450769.
  • Yavuz S، Komsuoğlu Çelikyurt FI (أغسطس 2021). "Antiviral treatment of COVID-19: An update". Turkish Journal of Medical Sciences. DOI:10.3906/sag-2106-250. PMID:34391321. S2CID:237054672.
  • Ahmad B، Batool M، Ain QU، Kim MS، Choi S (أغسطس 2021). "Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations". International Journal of Molecular Sciences. ج. 22 ع. 17: 9124. DOI:10.3390/ijms22179124. PMC:8430524. PMID:34502033.
  • Pedersen NC، Kim Y، Liu H، Galasiti Kankanamalage AC، Eckstrand C، Groutas WC، وآخرون (أبريل 2018). "Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis". Journal of Feline Medicine and Surgery. ج. 20 ع. 4: 378–392. DOI:10.1177/1098612X17729626. PMC:5871025. PMID:28901812.
  • Vuong W، Khan MB، Fischer C، Arutyunova E، Lamer T، Shields J، وآخرون (أغسطس 2020). "Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication". Nature Communications. ج. 11 ع. 1: 4282. DOI:10.1038/s41467-020-18096-2. PMC:7453019. PMID:32855413.

ncbi.nlm.nih.gov

racgp.org.au

www1.racgp.org.au

semanticscholar.org

api.semanticscholar.org

  • Schooley RT، Carlin AF، Beadle JR، Valiaeva N، Zhang XQ، Clark AE، وآخرون (سبتمبر 2021). "Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs". Antimicrobial Agents and Chemotherapy. ج. 65 ع. 10: e0115521. DOI:10.1128/AAC.01155-21. PMID:34310217. S2CID:236450769.
  • Yavuz S، Komsuoğlu Çelikyurt FI (أغسطس 2021). "Antiviral treatment of COVID-19: An update". Turkish Journal of Medical Sciences. DOI:10.3906/sag-2106-250. PMID:34391321. S2CID:237054672.

web.archive.org